Arbidol
Abdrcspc202001
Approved small_molecule completed
Quick answer
Arbidol for 2019-nCoV is a Approved program (small_molecule) at Jieming QU with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jieming QU
- Indication
- 2019-nCoV
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed